SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
19-Sep-22 8:37 AM View: | TrovaGene, Inc. (CRDF) | 16-Sep-22 | Private Purchase | 30,000 | $1.56 | $46,710.00 | 100% 30.0K to 60.0K | |
13-Sep-21 8:12 AM View: | TrovaGene, Inc. (CRDF) | 10-Sep-21 | Market Purchase | 30,000 | $6.47 | $194,000.00 | 100% 0 to 30.0K | (3%) |
12-Nov-20 6:00 AM View: | Cidara Therapeutics, Inc. (CDTX) | 10-Nov-20 | Market Purchase | 50,000 | $2.01 | $100,720.00 | 76% 65.83K to 115.83K | 5% |
23-Mar-20 7:16 PM View: | Cidara Therapeutics, Inc. (CDTX) | 19-Mar-20 | Grant | 25,000 | -- | -- | 68% 36.89K to 61.89K | |
30-Jan-20 8:49 PM View: | Cidara Therapeutics, Inc. (CDTX) | 28-Jan-20 | Exercise (in-the money or at-the-money) | 6,891 | $2.51 | $17,296.40 | 3% 205.0K to 211.89K | |
26-Sep-19 9:17 PM View: | Cidara Therapeutics, Inc. (CDTX) | 24-Sep-19 | Market Purchase | 30,000 | $1.91 | $57,240.00 | 17% 175.0K to 205.0K | 10% |
04-Nov-13 8:52 PM View: | Verenium Corp (VRNMDD.PK) | 31-Oct-13 | Disposition | 109,166 | $4.00 | $436,664.00 | (100%) 109.17K to 0 | |
16-May-12 5:29 PM View: | Verenium Corp (VRNMDD.PK) | 15-May-12 | Purchase | 4,994 | $3.65 | $18,228.10 | 5% 104.17K to 109.17K | |
29-Aug-11 3:25 PM View: | Verenium Corp (VRNMDD.PK) | 25-Aug-11 | Purchase | 25,000 | $3.18 | $79,500.00 | 32% 79.17K to 104.17K | |
16-Aug-11 3:19 PM View: | Verenium Corp (VRNMDD.PK) | 12-Aug-11 | Market Purchase | 25,000 | $1.69 | $42,250.00 | 46% 54.17K to 79.17K | (4%) |
17-Aug-10 5:17 PM View: | Verenium Corp (VRNMDD.PK) | 16-Aug-10 | Market Purchase | 25,150 | $2.51 | $63,126.50 | 87% 29.02K to 54.17K | 2% |
17-Aug-10 5:17 PM View: | Verenium Corp (VRNMDD.PK) | 13-Aug-10 | Market Purchase | 24,856 | $2.50 | $62,140.00 | 597% 4.17K to 29.02K | 2% |
27-May-09 6:40 PM View: | Verenium Corp (VRNMDD.PK) | 06-May-09 | Grant | 50,000 | -- | -- | 100% 0 to 50.0K |